CorVel Co. (NASDAQ:CRVL – Get Rating) Chairman V Gordon Clemons sold 667 shares of the company’s stock in a transaction dated Monday, April 11th. The stock was sold at an average price of $173.70, for a total value of $115,857.90. Following the completion of the transaction, the chairman now owns 900,000 shares of the company’s stock, valued at $156,330,000. The transaction was disclosed in a filing with the SEC, which is available at this link.
V Gordon Clemons also recently made the following trade(s):
- On Friday, April 8th, V Gordon Clemons sold 667 shares of CorVel stock. The shares were sold at an average price of $173.99, for a total value of $116,051.33.
- On Wednesday, April 6th, V Gordon Clemons sold 667 shares of CorVel stock. The shares were sold at an average price of $169.06, for a total value of $112,763.02.
- On Monday, April 4th, V Gordon Clemons sold 667 shares of CorVel stock. The shares were sold at an average price of $171.62, for a total value of $114,470.54.
- On Friday, March 18th, V Gordon Clemons sold 1,000 shares of CorVel stock. The shares were sold at an average price of $172.00, for a total value of $172,000.00.
- On Wednesday, March 16th, V Gordon Clemons sold 2,000 shares of CorVel stock. The shares were sold at an average price of $163.50, for a total value of $327,000.00.
- On Tuesday, March 1st, V Gordon Clemons sold 2,000 shares of CorVel stock. The shares were sold at an average price of $162.50, for a total value of $325,000.00.
- On Tuesday, February 22nd, V Gordon Clemons sold 1,000 shares of CorVel stock. The shares were sold at an average price of $161.00, for a total value of $161,000.00.
- On Wednesday, February 16th, V Gordon Clemons sold 2,000 shares of CorVel stock. The shares were sold at an average price of $165.59, for a total value of $331,180.00.
- On Monday, February 14th, V Gordon Clemons sold 2,000 shares of CorVel stock. The shares were sold at an average price of $160.00, for a total value of $320,000.00.
- On Thursday, February 10th, V Gordon Clemons sold 2,000 shares of CorVel stock. The shares were sold at an average price of $160.04, for a total value of $320,080.00.
Shares of NASDAQ:CRVL opened at $174.01 on Tuesday. CorVel Co. has a 52-week low of $105.81 and a 52-week high of $213.38. The firm has a market capitalization of $3.07 billion, a P/E ratio of 51.64 and a beta of 0.97. The stock has a 50 day moving average price of $163.61 and a 200-day moving average price of $179.80.
CRVL has been the subject of several research reports. StockNews.com initiated coverage on CorVel in a research report on Thursday, March 31st. They issued a “buy” rating for the company. TheStreet lowered CorVel from a “b” rating to a “c+” rating in a research report on Monday, February 7th.
A number of institutional investors and hedge funds have recently modified their holdings of CRVL. FMR LLC boosted its stake in CorVel by 92.6% during the 1st quarter. FMR LLC now owns 53,900 shares of the business services provider’s stock valued at $3,516,000 after purchasing an additional 25,918 shares during the last quarter. Royal Bank of Canada boosted its stake in CorVel by 87.8% during the 2nd quarter. Royal Bank of Canada now owns 1,110 shares of the business services provider’s stock valued at $149,000 after purchasing an additional 519 shares during the last quarter. Morgan Stanley boosted its stake in CorVel by 36.1% during the 2nd quarter. Morgan Stanley now owns 44,899 shares of the business services provider’s stock valued at $6,030,000 after purchasing an additional 11,907 shares during the last quarter. Texas Permanent School Fund boosted its stake in CorVel by 2.9% during the 3rd quarter. Texas Permanent School Fund now owns 6,984 shares of the business services provider’s stock valued at $1,301,000 after purchasing an additional 199 shares during the last quarter. Finally, Busey Wealth Management purchased a new position in shares of CorVel in the 3rd quarter worth $363,000. Institutional investors and hedge funds own 50.56% of the company’s stock.
CorVel Company Profile (Get Rating)
CorVel Corporation provides workers' compensation, auto, liability, and health solutions for employers, third party administrators, insurance companies, and government agencies to assist them in managing the medical costs and monitoring the quality of care associated with healthcare claims. It applies technology, including artificial intelligence, machine learning, and natural language processing to enhance the managing of episodes of care and the related health care costs.
Recommended Stories
- Get a free copy of the StockNews.com research report on CorVel (CRVL)
- 3 Best Recession-Resistant, Cost-Conscious Retail Stocks to Take a Look at Right Now
- Simply Good Foods Stock is a Healthy Defensive Play
- Schlumberger Analyst Coverage Drives Market HigherÂ
- Poor Timing Will Put Delta Air Lines on Standby For Risk-Off Investors
- 3 Tech Stocks to Buy for Retirement
Receive News & Ratings for CorVel Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CorVel and related companies with MarketBeat.com's FREE daily email newsletter.